Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
15,576,080
-
Share change
-
+13,546,617
-
Total reported value
-
$86,448,000
-
Put/Call ratio
-
3.8%
-
Price per share
-
$5.55
-
Number of holders
-
39
-
Value change
-
+$75,184,349
-
Number of buys
-
37
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q4 2018
As of 31 Dec 2018,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,576,080 shares.
The largest 10 holders included
NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, Aisling Capital Management LP, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, 683 Capital Management, LLC, Vanguard Group Inc, GEODE CAPITAL MANAGEMENT, LLC, BARCLAYS PLC, and Laurion Capital Management LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.